ATE544472T1 - Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie - Google Patents
Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapieInfo
- Publication number
- ATE544472T1 ATE544472T1 AT08022155T AT08022155T ATE544472T1 AT E544472 T1 ATE544472 T1 AT E544472T1 AT 08022155 T AT08022155 T AT 08022155T AT 08022155 T AT08022155 T AT 08022155T AT E544472 T1 ATE544472 T1 AT E544472T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium phosphate
- nanoparticle formulations
- photosensitizer
- preferred
- photosensitizers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08022155A EP2198885B1 (de) | 2008-12-19 | 2008-12-19 | Kalziumphosphat-Nanopartikel als Farbstoffträger für die photodynamische Therapie |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE544472T1 true ATE544472T1 (de) | 2012-02-15 |
Family
ID=40677783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08022155T ATE544472T1 (de) | 2008-12-19 | 2008-12-19 | Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie |
Country Status (7)
Country | Link |
---|---|
US (1) | US8956648B2 (de) |
EP (1) | EP2198885B1 (de) |
JP (1) | JP5138818B2 (de) |
CN (1) | CN102256622B (de) |
AT (1) | ATE544472T1 (de) |
ES (1) | ES2381022T3 (de) |
WO (1) | WO2010078941A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010025476B4 (de) * | 2010-06-29 | 2014-04-30 | Universität des Saarlandes | Komplexe mit Polystyrolsulfonat |
WO2012145801A1 (en) * | 2011-04-29 | 2012-11-01 | Jagat Rakesh Kanwar | Nanoparticle |
WO2013009701A2 (en) | 2011-07-08 | 2013-01-17 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
RU2015137815A (ru) * | 2013-02-05 | 2017-03-13 | 1ГЛОУБ ХЕЛТ ИНСТИТЬЮТ ЭлЭлСи | Биодеградируемые и клинически совместимые наночастицы в качестве носителей для доставки лекарственного средства |
CN103202316A (zh) * | 2013-03-06 | 2013-07-17 | 安徽大学 | 一种具有抑菌功能的吩噻嗪衍生物/银纳米复合材料及其制备方法 |
IN2013DE02943A (de) * | 2013-10-04 | 2015-04-10 | Sanjay Banerji | |
KR101567717B1 (ko) | 2014-07-24 | 2015-11-10 | 가톨릭대학교 산학협력단 | 칼슘 이온 및 친수성 음이온성 광민감제를 이용한 나노복합체의 제조방법 및 상기 나노복합체를 이용한 약물전달체 |
KR101622031B1 (ko) * | 2014-07-25 | 2016-05-19 | 경희대학교 산학협력단 | 광감작제 담지 탄산칼슘 복합 나노입자, 이의 제조방법 및 이를 포함하는 초음파 조영 및 광역학 치료용 조성물 |
EP3229783A4 (de) * | 2014-12-09 | 2018-08-08 | Belmont University | Pharmazeutische halbfeste gele mit eingeschlossenen calciumphosphatnanopartikeln |
WO2017096342A1 (en) | 2015-12-03 | 2017-06-08 | Amrita Vishwa Vidyapeetham | Radio-wave responsive doped nanoparticles for image-guided therapeutics |
CN105954268B (zh) * | 2016-04-22 | 2019-01-11 | 华南师范大学 | 一种基于四氧化三铁纳米簇催化信号放大的可视化检测传感器及其构建与应用 |
CN109415210B (zh) * | 2016-06-30 | 2023-04-21 | 株式会社索夫塞拉 | 磷酸钙烧结体粒子及其制造方法 |
WO2018106931A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
EP3638367A4 (de) | 2017-08-02 | 2021-07-21 | The University of Chicago | Nanoskalige metallorganische schichten und metallorganische nanoplatten für die röntgenstrahlinduzierte photodynamische therapie, strahlentherapie, dynamische strahlentherapie, chemotherapie, immuntherapie und eine beliebige kombination davon |
EP3789760A1 (de) * | 2019-09-05 | 2021-03-10 | PreSens Precision Sensing GmbH | Kohlendioxidgassensor |
CN111973573B (zh) * | 2020-08-04 | 2022-10-18 | 中山大学附属第七医院(深圳) | 一种磷酸钙纳米颗粒及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455858B2 (en) | 2002-05-16 | 2008-11-25 | Qlt Inc. | Compositions and methods for delivery of photosensitive drugs |
US20090246127A1 (en) * | 2004-12-17 | 2009-10-01 | Koninklijke Philips Electronics, N.V. | Targeting agents for molecular imaging |
US20070218049A1 (en) | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
WO2006093891A2 (en) * | 2005-02-28 | 2006-09-08 | The General Hospital Corporation | Photosensitizers for targeted photodynamic therapy |
DE102005016873A1 (de) * | 2005-04-12 | 2006-10-19 | Magforce Nanotechnologies Ag | Nanopartikel-Wirstoff-Konjugate |
US20080241256A1 (en) | 2007-03-30 | 2008-10-02 | Liisa Kuhn | Targeted active agent delivery system based on calcium phosphate nanoparticles |
WO2009099136A1 (ja) * | 2008-02-07 | 2009-08-13 | Kuraray Medical Inc. | リン酸カルシウム組成物及びその製造方法 |
-
2008
- 2008-12-19 EP EP08022155A patent/EP2198885B1/de active Active
- 2008-12-19 ES ES08022155T patent/ES2381022T3/es active Active
- 2008-12-19 AT AT08022155T patent/ATE544472T1/de active
-
2009
- 2009-12-18 CN CN200980151463.5A patent/CN102256622B/zh not_active Expired - Fee Related
- 2009-12-18 US US13/140,855 patent/US8956648B2/en active Active
- 2009-12-18 JP JP2011541225A patent/JP5138818B2/ja not_active Expired - Fee Related
- 2009-12-18 WO PCT/EP2009/009142 patent/WO2010078941A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN102256622A (zh) | 2011-11-23 |
JP2012512817A (ja) | 2012-06-07 |
ES2381022T3 (es) | 2012-05-22 |
US8956648B2 (en) | 2015-02-17 |
EP2198885A1 (de) | 2010-06-23 |
WO2010078941A1 (en) | 2010-07-15 |
US20110257586A1 (en) | 2011-10-20 |
JP5138818B2 (ja) | 2013-02-06 |
CN102256622B (zh) | 2014-10-29 |
EP2198885B1 (de) | 2012-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE544472T1 (de) | Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie | |
Hamblin | Fullerenes as photosensitizers in photodynamic therapy: pros and cons | |
Qi et al. | Novel nanomaterial-based antibacterial photodynamic therapies to combat oral bacterial biofilms and infectious diseases | |
Kustov et al. | Synthesis and investigation of water-soluble chlorophyll pigments for antimicrobial photodynamic therapy | |
Nguyen et al. | Organic photosensitizers for antimicrobial phototherapy | |
Kashef et al. | Advances in antimicrobial photodynamic inactivation at the nanoscale | |
Zeng et al. | H2O2-responsive biodegradable nanomedicine for cancer-selective dual-modal imaging guided precise photodynamic therapy | |
Hamblin | Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes | |
Huang et al. | Functionalized fullerenes in photodynamic therapy | |
Ai et al. | Recent advances of light-mediated theranostics | |
Yin et al. | Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: oxygen-independent photokilling in presence of azide and new mechanistic insights | |
Maisch | A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment | |
Hamblin et al. | Nanotechnology for photodynamic therapy: A perspective from the laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School | |
Sharma et al. | Photodynamic therapy for cancer and for infections: what is the difference? | |
Liang et al. | Photodynamic therapy as an antifungal treatment | |
Gonzalez-Delgado et al. | Use of photosensitizers in semisolid formulations for microbial photodynamic inactivation: miniperspective | |
Kolarikova et al. | Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments | |
Huang et al. | Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70] fullerene: in vitro and in vivo studies | |
Robinson‐Duggon et al. | Potential applications of cucurbit [n] urils inclusion complexes in photodynamic therapy | |
Pucelik et al. | Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms | |
de Freitas et al. | Antimicrobial photoinactivation with functionalized fullerenes | |
Scanone et al. | Porphyrins containing basic aliphatic amino groups as potential broad-spectrum antimicrobial agents | |
Meng et al. | Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy | |
Laroui et al. | Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes | |
Uzdensky | The biophysical aspects of photodynamic therapy |